The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Thymoma and Thymic Carcinoma: Multidisciplinary Approach

Anterior mediastinal epithelial tumors with paraneoplastic associations and stage-directed treatment

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Thymoma and Thymic Carcinoma: Multidisciplinary Approach?

Thymomas represent the most common anterior mediastinal mass in adults, classified by WHO histology into types A, AB, B1, B2, B3 and thymic carcinoma with progressively aggressive behavior.

Masaoka-Koga staging from stage I (encapsulated) through stage IV (pleural, pericardial or distant metastasis) guides prognosis and treatment.

Paraneoplastic syndromes occur in 30 to 50 percent of thymoma patients including myasthenia gravis, pure red cell aplasia and hypogammaglobulinemia (Good syndrome).

Thymic carcinoma is more aggressive with frequent local invasion, distant metastasis and worse prognosis compared with thymoma.

Diagnosis combines CT, MRI, octreotide scintigraphy and tissue biopsy though core biopsy is preferred over fine needle aspiration.

Symptoms

Asymptomatic incidental finding on chest imaging in approximately one third of patients.
Local symptoms from mass effect including chest pain, cough, dyspnea and superior vena cava syndrome.
Myasthenia gravis symptoms with ptosis, diplopia, dysphagia, limb weakness and respiratory compromise.
Pure red cell aplasia with severe anemia requiring transfusion support.
Hypogammaglobulinemia with recurrent infections, particularly sinopulmonary.

Risk Factors

No clearly established environmental risk factors though age peak in fourth to seventh decades.
Autoimmune diseases including myasthenia gravis, lupus and rheumatoid arthritis are associated.
Prior radiation therapy to chest area in some cases.
MEN1 syndrome with rare association.
No strong familial clustering except in specific genetic syndromes.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Anterior mediastinal mass identified on imaging requires thoracic surgery and oncology consultation.
  • New onset myasthenia gravis warrants chest imaging to evaluate for associated thymoma.
  • Unexplained pure red cell aplasia or hypogammaglobulinemia should prompt thymic evaluation.
  • Mediastinal mass with concerning features (irregular borders, invasion of adjacent structures) needs urgent oncologic workup.
  • Long-term surveillance after treatment monitors for recurrence and emergent paraneoplastic syndromes.

Treatment Methods

01
Complete surgical resection via median sternotomy or minimally invasive approach is the cornerstone for resectable disease.
02
Adjuvant radiation therapy is recommended for incompletely resected disease, stage III to IV thymoma and thymic carcinoma.
03
Neoadjuvant chemotherapy with cisplatin-based regimens for borderline resectable or locally advanced disease.
04
Systemic chemotherapy and targeted therapy options for unresectable or metastatic disease including pemetrexed, paclitaxel and emerging agents.
05
Multidisciplinary care, perioperative management of myasthenia gravis with plasmapheresis or immunoglobulin, comprehensive supportive care and long-term follow-up given delayed recurrence pattern optimize outcomes for these rare tumors.

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.